Patent ID: 11864888
Assignee: ROCHE DIABETES CARE, INC.
Field: Medical technology (Instruments)
Classification: CPC A  G | IPC A  G

Claim 6:
7. A method for collecting blood glucose measures from a patient, comprising:
presenting, by a diabetes management device, the patient with a plurality of contextual criterion for a structured test, where the structured test comprises of a series of steps to be performed by the patient to evaluate an effect of one or more contextual criterion on the blood glucose measures of the patient;
receiving, by the diabetes management device, selection of one or more contextual criterion by the patient from the plurality of contextual criterion where the receipt of the selection of the one or more contextual criterion is in response to presenting the patient with the plurality of contextual criterion;
constructing, by the diabetes management device, the structured test using a test template that specifies one or more collection events for collecting the blood glucose measures and using the contextual criterion selected by the patient, where the construction of the structured test is in response to receiving the selection of the one or more contextual criterion;
administering, by the diabetes management device, the structured test to the patient multiple times over a period of time, thereby acquiring one or more sample instances for each structured test in a series of administered structured tests, where administering the structured test includes prompting the patient with prompts to perform the series of steps, receiving replies from the patient in response to prompting the patient with the prompts, and where at least one step in the series of steps is measuring a blood glucose level of a sample of blood using a glucose meter, a first step in the series of steps is providing a first sample of blood to the glucose meter before a test event and a second step in the series of steps is providing a second sample of blood after the test event;
evaluating, by the diabetes management device, whether a given contextual criterion selected by the patient has been met during the administration of a given structured test; and
tagging, by the diabetes management device, sample instances acquired during the given structured test as non-compliant or discarding the sample instances when the given contextual criterion was not met during the administration of the given structured test.